BioSpace News Archive

FDA

Jazz Pharma Wins FDA Approval for Lower-Sodium Narcolepsy Treatment

The U.S. Food and Drug Administration (FDA) approved Xywav, the first new treatment option indicated for both cataplexy and excessive daytime sleepiness in people living with narcolepsy in more than 15 years.

July 22, 2020
·
2 min read
·
Alex Keown
Biotech Beach

Locanabio’s Combo RNA Modification Platform Targets Multiple RNA Dysfunctions with One Injection

Locanabio combines gene therapy with RNA modification for a novel, highly flexible platform that can modify, replace or eliminate dysfunctional RNA. Gene therapy and RNA modification have each been used before. It’s the combination that makes it unique.

July 22, 2020
·
4 min read
·
Gail Dutton
BioSpace Global Roundup, July 23

Biopharma and life sciences companies from across the globe provide updates on their pipelines and businesses.

July 22, 2020
·
5 min read
·
Alex Keown
Policy

U.S. Government Indicts Chinese Hackers for Stealing COVID-19 Data and More

Two Chinese nationals have been indicted for hacking into the computer systems of hundreds of companies, governments, non-governmental organizations and more to steal trade secrets, including data on treatments related to COVID-19.

July 22, 2020
·
3 min read
·
Alex Keown
Biotech Bay

With $54 Million in Financing, Olema Oncology Takes Aim at Breast Cancer

San Francisco-based Olema Oncology secured $54 million in an oversubscribed Series B financing round to support the development of its lead breast cancer treatment, as well as expand its ongoing research and development programs.

July 22, 2020
·
2 min read
·
Alex Keown
Business

Report: Novavax Awards Stock Options to Executives for Phase II Vaccine Milestone

According to the report, the options are worth $101 million and do not hinge on the clinical success of the vaccine program.

July 22, 2020
·
2 min read
·
Alex Keown
Policy

Pfizer and BioNTech Ink $1.95 Billion COVID-19 Vaccine Deal with U.S. Government

Only days after announcing a COVID-19 vaccine production deal with the UK government, New York-based Pfizer and Germany-based BioNTech signed an even bigger deal with the U.S. government.

July 22, 2020
·
3 min read
·
Mark Terry
Drug Development

AbbVie’s Rinvoq Hits the Mark in Pivotal Phase III Dermatitis Trial

AbbVie announced that its Rinvoq (upadacitinib) as a monotherapy hit both primary and all secondary endpoints in the second Phase III trial, Measure Up 2, in patients with moderate to severe atopic dermatitis.

July 22, 2020
·
2 min read
·
Mark Terry
Drug Development

How Long Do Antibodies Against COVID-19 Really Last?

How long do antibodies against SARS-CoV-2, the novel coronavirus that causes the disease, last? And if they are gone, is your immune system still able to offer protection against getting infected again?

July 22, 2020
·
4 min read
·
Mark Terry
BioForest

In Response to National GBM Awareness Day and to Improve Patient Access, The EndBrainCancer Initiative Launches Telehealth and Case Management Services

The EndBrainCancer Initiative (EBCI) announced today that it is launching a new initiative to better support patients with brain tumors and their caregivers in response to the COVID-19 crisis.

July 22, 2020
·
3 min read